載入...
Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine
Over the past decade, patients with advanced non-small-cell lung cancer (NSCLC) have witnessed substantial advances in regards to therapeutic alternatives. Among newly developed agents, angiogenesis inhibitors were extensively tested in different settings and have produced some favorable outcomes de...
Na minha lista:
| 發表在: | Front Oncol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5372785/ https://ncbi.nlm.nih.gov/pubmed/28424759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2017.00052 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|